LAUREN PEREZ: Open Payments
NPI 1992101935 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 17 payments from 7 companies in 2025. Trend: 2023 $228 · 2024 $313 · 2025 $316
Food & beverage: $283Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Novo Nordisk Inc | 2 | $53 |
| Boston Scientific Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, LifeVest, CAMZYOS, WATCHMAN FLX, Wegovy, REPATHA.
Industry payments across KS — which companies pay providers there.
